NCT01647932View on ClinicalTrials.gov

Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions
Heart Failure
Interventions
DRUG

hydrochlorothiazide

hydrochlorothiazide according to clearance of creatinine; \>50ml/min 25mg daily, 20-50ml/min 50mg daily amd \<20ml/min 100mg daily.

DRUG

Placebo

Placebo according to clearance of creatinine; \>50ml/min 1/2 pill daily, 20-50ml/min 1 pill daily amd \<20ml/min 2 pills daily.

Trial Locations (1)

17800

Internal Medicine Service, Hospital d'Olot (Girona), Olot

All Listed Sponsors
lead

Spanish Society of Internal Medicine

OTHER

NCT01647932 - Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure | Biotech Hunter | Biotech Hunter